Price Alert

Impact BioMedical Inc. (IBO)

AMEX: IBO · Real-Time Price · USD

0.58

0.01 (2.29%)

At close: Aug 15, 2025, 3:59 PM

0.56

-2.75%

After-hours: Aug 15, 2025, 07:32 PM EDT

Impact BioMedical Balance Sheet Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jul 31, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Cash & Equivalents	1.32M	2M	2.67M	2K	2K	1K	273.01	3.97	353.05K	192K	703.67K	726.05K	1.95M	58.17	4.19M	53.06K	123.27K
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1.03K	n/a	n/a	n/a	n/a	n/a	6.09K	n/a	n/a	n/a
Other Long-Term Assets	n/a	17K	59K	67K	n/a	n/a	n/a	n/a	1.55M	1.55M	n/a	n/a	n/a	6.42K	n/a	n/a	n/a
Receivables	204K	184K	142K	263K	331K	331K	130.39	n/a	135.21K	491.9K	116.57K	231K	209.33K	n/a	450.69K	11.19K	18.35K
Inventory	489K	n/a	n/a	n/a	n/a	n/a	n/a	5.30	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	172K	n/a	365K	42K	2K	n/a	277.08	451.73	n/a	n/a	n/a	n/a	n/a	303.49	n/a	n/a	n/a
Total Current Assets	2.18M	2.45M	3.17M	307K	335K	332K	680.48	461.01	595.08K	692.87K	859.63K	1.02M	2.3M	362.92	4.91M	5.11M	2.2M
Property-Plant & Equipment	16K	17K	282K	284K	285K	287K	392.53	384.17	3.73M	3.76M	5.38M	5.3M	6.61M	n/a	6.68M	892.00	969.00
Goodwill & Intangibles	17.85M	17.81M	43.18M	43.46M	43.74M	44.01M	60.16K	59.04K	n/a	n/a	n/a	n/a	1.46M	58.47K	1.46M	n/a	n/a
Total Long-Term Assets	17.87M	17.84M	43.52M	43.81M	44.02M	44.3M	60.55K	60.46K	5.28M	5.31M	5.38M	5.3M	8.07M	70.99K	8.14M	892.00	969.00
Total Assets	20.05M	20.29M	46.7M	44.12M	44.36M	44.63M	61.23K	60.92K	5.87M	6M	6.24M	6.32M	10.37M	71.35K	13.05M	5.11M	2.2M
Account Payables	615K	713K	1M	986K	1.02M	832K	646.52	398.74	361.2K	531.41K	172.42K	171.79K	278.78K	145.42	477.05K	n/a	n/a
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	304.8K	271.98K	165.9K	165.9K	179.11K	n/a	20.18K	n/a	n/a
Short-Term Debt	9.14M	8.88M	35K	13.45M	12.79M	12.07M	16K	15.57K	123.9K	111.27K	1.55M	n/a	188.42K	15.84K	436.81K	n/a	n/a
Other Current Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	357.3K	279.65K	391.69K	299.3K	310.85K	n/a	901.32K	5.08M	2.14M
Total Current Liabilities	9.97M	9.79M	1.14M	14.5M	13.86M	13.14M	16.66K	15.97K	1.15M	1.19M	2.28M	636.99K	957.16K	15.99K	1.38M	5.08M	2.14M
Long-Term Debt	n/a	n/a	7.97M	n/a	n/a	n/a	n/a	n/a	2.53M	2.17M	748.22K	1.74M	1.67M	n/a	1.72M	60K	60K
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	4.39K	4.29K	n/a	n/a	n/a	n/a	n/a	4.88K	10.00	n/a	n/a
Total Long-Term Liabilities	3.27M	3.27M	11.21M	3.23M	3.23M	3.23M	4.39K	4.29K	2.53M	2.17M	748.22K	1.74M	1.67M	4.88K	1.72M	60K	60K
Total Liabilities	13.24M	13.05M	12.34M	17.73M	17.09M	16.37M	21.05K	20.25K	3.67M	3.36M	3.03M	2.37M	2.63M	20.87K	3.11M	5.14M	2.2M
Total Debt	9.14M	8.88M	8.01M	13.45M	12.79M	12.07M	16K	15.57K	2.65M	2.28M	2.3M	1.74M	1.86M	15.84K	2.16M	60K	60K
Common Stock	12K	11K	11K	10K	10K	10K	95.08	165.59	22.83M	22.83M	22.81M	22.8M	20.17M	158.07	20.15M	791K	791K
Retained Earnings	-38.94M	-37.67M	-10.56M	-14.81M	-13.92M	-12.96M	-15.85K	-13.99K	-24.86M	-24.38M	-23.58M	-22.74M	-16.19M	-1.99K	-13.98M	-938.52K	-915.36K
Comprehensive Income	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	4.23M	4.19M	3.98M	3.88M	3.76M	n/a	3.77M	n/a	n/a
Shareholders Equity	3.84M	4.26M	31.35M	23.37M	24.26M	25.22M	36.01K	36.59K	2.2M	2.64M	3.21M	3.94M	7.74M	46.29K	9.94M	-27.62K	-4.46K
Total Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1.03K	n/a	n/a	n/a	n/a	n/a	6.09K	n/a	n/a	n/a